Need professional-grade analysis? Visit stockanalysis.com
$1.08B
50.79
470
N/A
Nanosonics Ltd (NAN) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at AUD3.75, up 5.93% from the previous close.
Over the past year, NAN has traded between a low of AUD3.24 and a high of AUD4.90. The stock has lost 17.2% over this period. It is currently 23.5% below its 52-week high.
Nanosonics Ltd has a market capitalization of $1.08B, with a price-to-earnings ratio of 50.79.
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Side-by-side comparison against top Healthcare peers.